chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant concerning a female nurse splashed Gardasil in her eyes. Subsequently, the nurse's eyes were blurry and burning (patient outcome not reported). The patient sought unspecified medical attention. Additional information has been requested.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced PYREXIA (Fever). On 22-May-2021, PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Mom states child had high temp & began shaking evening of immun; Taken to ER MD saw & admitted overnight for observation; Temp 105.4 when in ER pt dx w/otitis media, bilateral by MD;
7-4-07 Numbness started on lt side of face and progressed to entire face.  Tongue felt thick. Numbness worsened with time.  7-9-07 In the middle of night, client felt prickling and numbness in both arms.  Saw PCP next am.  The sensation had resolved by the time of the drs visit.  7-12-07 Spoke with client this am, symptoms some better.  At this time the only area affect is her chin and jaw.
I  don't recall the exact meningitis vaccine I was given but based on research i believe it was the one selected. Sudden onset in a matter of hours of neurological symptoms 3-4 weeks after vaccination in an otherwise healthy 18 year old F. Developed tingling in the forearms and hands; and tingling below the knees through the feet. Tinnitus developed, stiff neck, burning feet, vertigo, extreme headaches, dizziness, jaw pain, muscle aches, muscle twitches, and muscle pains, fatigue, and weakness.
MODERNA VACCINE #3 - LOT # 042J21A. DATE: 02/23/2022  MODERNA VACCINE #4 - LOT # 056A22A. DATE: 07/20/2022  CAUSE OF DEATH ON 08/15/2022 = COVID-19
COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/10/21 (EN6203) Pfizer Dose 2 4/2/21 (ER8734) COVID Positive 12/1/21  12/1/21:  Patient is 90-year-old female past medical history significant for essential hypertension, hyperlipidemia, obesity, chronic cough  Patient presented with generalized weakness and cough of 2 days duration.  Patient progressively started to feel much worse with worsening of cough; has been vaccinated for COVID but has contact with family members having coli 19 infection.  Patient rapid test for COVID at with compass was negative.  In the emergency room patient was febrile tachypneic and tachycardic and was requiring oxygen supplementation 7 LPM than 15 liter/minute; had to be transition to BiPAP after which saturation improved.  Lab was significant for hyponatremia of 132; anion gap of 17 with elevated glucose of 121; creatinine was elevated 1.02.  And proBNP was also elevated 6622 with elevated troponin of 1.05.  Cell count showed thrombocytopenia of 118 with lymphopenia; D-dimer was also elevated 1.31.  Portable chest x-ray shows scattered bilateral area of airspace disease likely representing multilobar pneumonia or viral pneumonitis  CT angio of the chest was unremarkable for pulmonary embolism; however showed scattered bilateral area of airspace disease likely representing viral pneumonitis or multilobar pneumonia  12/22/21: 90-year-old woman who presented emergency department with generalized weakness, fever and malaise following exposure to a COVID best if individual.  COVID post 19 PCR was noted to be positive, she was hypoxic requiring initiation of supplemental oxygen.  She was admitted to the hospitalist service where progressive increasing oxygen requirements was noted despite treatment with IV remdesivir, Actemra, steroids, empiric antibiotic therapy.  She was transferred to the intensive care unit where she was managed with high-flow oxygen and BiPAP, also required brief period of pressor support on account of hypotension.  Subsequent improvement noted in oxygen requirements and she did not require intubation, she was then transferred to the floor she has gradually been weaned down from high-flow oxygen down to 5 liters/minutes of supplemental oxygen via nasal cannula at the time of discharge.  She is in fair medical condition and has been discharged to skilled nursing facility for continued rehabilitation.
not slept; headache; neck ache; energy bursts; This is a spontaneous report from a contactable nurse. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration at left arm on 12Mar2021 at 12:15 hours (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history of the patient was reported as sensitivity to latex. Concomitant medication was not taken by the patient. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 12Mar2021 the patient experienced events energy bursts first in her left arm, then left torso, then lower left leg, lower right leg, right torso and right arm. On 12Mar2021 at 20:00, the patient experienced events headache and neck ache. On 13Mar2021, the patient had not slept more than 1 to 2 hours without taking over the counter (OTC) sleep aid. It was also reported that, the patient did not feel tired but she never had sleeping issue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as result of events headache, neck ache included treatment with TYLENOL 1000mg at 03:00 and for sleep an OTC sleep aid. The clinical outcomes of events energy bursts, headache, neck ache and sleeplessness were not resolved at the time of this report.   No follow-up attempts are needed; no further information is expected.
on 10/27/2021 after getting home from work patient noticed around 9pm her right arm at the flu injection site was swollen, had a hard knot about the size of a quarter, reddened, warm to touch and sore.  She took 2 tylenol and had no relief. On the AM of 10/28/2021 she went to the Occupational Health Clinic and saw Dr. because her arm remained the same as the previous evening. She had no rash, no shortness of breath or throat closing.  The local reaction lasted about 48 hours.
Vaccine was stored after expiration date in the refrigerator; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It mentioned that the vial was placed in the refrigerator on 04-Nov-2021, the vial did not undergo any temperature excursion and patient did not experienced any adverse events.  No treatment medications were reported.
Initial report received from a healthcare professional on 05 December 2013. This is a summary case of 30-35 patients of unspecified demographics. Some 30-35 patients had received an intradermal dose of FLUZONE ID vaccine, batch number: UT4277AA (dose number and anatomical site of vaccination was not reported) on an unspecified date in October 2013. On an unspecified date in October 2013 after vaccination, the patients developed welts at injection site. The welts at the vaccination site had resolved in 2-3 days without any medical intervention. Laboratory investigations were not reported. Documents held by sender: none. Follow-up information received from a healthcare professional on 21 January 2014. The patient had received previously 10 doses of FLUZONE ID (Lot number, route and site of vaccination unknown) on an unspecified date.
the day following vax pt exp redness at inject site; in 1998 pt exp a local site react post vax
Fever that lasted overnight, rash that lasted for over a week. Diarrhea for over a week. Headaches for 5 days. Site of vaccine was extremely hot compared to rest of body.
PT SAYS HER ARM BECAME SWOLLEN AND WARM TO TOUCH A FEW HOURS AFTER INJECTION. SHE RECEIVED VACCINATION 12/24/2021 AND REPORTED ADVERSE REACTION 121/28/2021
fully vaccinated for covid- rec'd 2nd dose of Moderna 2/8/2021 11/9/21 developed cough and had decrease in oxygen saturation- tested positive for covid on now molecular test
Pain and swelling at injection site, fatigue, muscle cramps and nausea. Lasted approximately 24 hours.
PT SAID THAT SHE HAD SYMPTOMS ON HER WAISTLINE THAT RESEMBLED A SHINGLES RASH THAT STARTED THE DAY AFTER HER VACCINE. SHE SAID IT WAS NOT SEVERE AND WAS MANAGING WITHOUT TALKING TO HER DOCTOR.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age. No concurrent conditions or medical history were provided. In 2012 (exact date unknown), the patient was vaccinated with a dose of ZOSTAVAX injection (strength, dose, route of administration, indication, lot# and expiry date unspecified). No concomitant medications were reported. The pharmacist reported that in 2012 (dates unspecified), the consumer developed Guillain-Barre post vaccination, was hospitalized for one month, and had to go through physical therapy. At the time of report, the patient was okay (date of recovery unknown). The relatedness between the event and ZOSTAVAX was not reported. Upon internal review the Guillain-Barre syndrome was considered to be medically significant. Additional information has been requested.
Patient had a negative Varicella Zoster titer result. Was immunized for Varicella 9/15/14, developed chickenpox on 10/3/14 which was confirmed at time of appt. with his doctor 10/6/14.
This spontaneous report was received from a registered nurse referring to 3 patients of unknown age and gender. The patient's pertinent medical history and concurrent condition were not reported. On 14-AUG-2015, the nurse reported that the patients possibly received a dose of improperly stored VARIVAX (dose, frequency and route were unknown), lot# L008272, expiration date 11-MAR-2017. No concomitant medication was reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. This is one of several reports from the same reporter. Additional information has been requested.
SOLDIER SAT DOWN AT ONE STATION AND RECIEVED ANTHRAX#2.UPON SCREENING OF THE SMALLOX FORM THE SOLDIER WAS SENT TO THE SMALLPOX TABLE. AFTER GIVING THE SMALLPOX SSG ROUSE EXPLANED THAT HE WAS GIVING THE 2nd ANTHRAX. THE SOLDIER SAID OK. A SECOND ANTHRAX WAS GIVEN. TIME BETWEEN ABOUT 15MIN.
Patient reported was > 6 mos and meet criteria for COVID Vaccine Booster. After administration when documenting it was noted that patient received 2nd COVID vaccine on 5/13/21 which was <6mos by 6 days.  Patient was disclosed and consulted by our provider with no reported issues.
Patient presented with fatigue, SOB to ER on 10/7/23. Sore throat and other symptoms started 8-9 days prior to admission. Provider consulted on 10/9/23 and stated patient was improved and hopeful for discharge on 10/9/23.
Information has been received from a woman at a pediatric office concerning a 17-year-old female who on 11-AUG-2006 was vaccinated in the right arm with a second dose of Varivax (lot# 652725/0249F). There was no illness at the time of vaccination. On the morning of 12-AUG-2006 the patient experienced swelling, redness at the injection site and hot to touch. It was reported that the patient recovered as of 16-AUG-2006. Additional information has been requested.
Patient received the vaccine at her normal check-up, and had a brief syncopal episode 3 minutes later. Had no loss of consciousness, and no fall. Returned to normal within 15 minutes.
Pt was given 2nd dose of Pfizer  COVID vaccine.  After about 20min, pt complained of fast heart rate. No other symptoms.  Vital signs were checked.  BP: 137/68, HR: 92, and O2 Sat 98%. Pt was observed for another 10-15 minutes.  Offered pt water to drink, but she refused. Stated she did not want to have to remove her mask to drink.  After 10-15 minutes, vital signs were re-checked.  HR:78 and O2 sat 98% on room air.  Pt reported she felt fine and was able to leave clinic.
About 2-3 hours after receipt of AVA (2), patient noted that her face and ears were hot and her back itched. She noted pencil sized raised non-red pruritic papules on her chest, back, arms and legs. Pt went to sick call (no documentation) and was told that she may be having an allergic reaction to the vaccine. She was treated with BENADRYL which she took sporadically. Symptoms persisted 2-3 weeks. She denies any angioedema, wheezing, lightheadedness or loss of consciousness. Patient had no reaction following first anthrax vaccine except some local erythema. She has not received any anthrax vaccines since, but has received multiple flu vaccines and typhoid vaccine. She admits to one other episode of hives many years ago with no identifier. No allergy to foods. No allergy to insect bites/stings. No allergy to animals. An allergy to latex --> runny nose and nasal congestion. No rash, hives, wheezing. Allergic to CELEXA --> hives, vomiting.
redness with warmth and tenderness approximately 3"x3" area, over 3 days and current. also causing numbness to arm and hand at night interrupting sleep .
Short of breath just walking- wheezing-dizziness- It is now a month later and still short of breath in all that I do Primary care dr. gave 2 series of steroids and bacterial infection meds (no help) chest xray--cta scan- ekg-he couldn't see a major lung problem so he sent me to the hospital for a cardiac stress test. Hospitalized for 5 days-more steroids and antibacterial in saline solution- oxygen blood gas level down so administered-cardiac stress test- respitory stress test-respitory therapy-blood drawn all in normal ranges-blood gases normal-hematology-normal,chemistry-normal,immuno/serology-normal, abdomen ultrasound
stomach burning; Taste metallic; This is a spontaneous report from a contactable consumer (patient). An 80-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN5318) via an unspecified route of administration, administered in Arm Right on 29Jan2021 at 13:30 (at the age of 80-year-old) as dose 1, single for COVID-19 immunisation. Patient's Medical History (including any illness at time of vaccination) was reported as no. Concomitant medications were reported as no. History of all previous immunization with the Pfizer vaccine considered as suspect was reported as none. Additional vaccines administered on same date of the Pfizer Suspect was reported as none. Prior Vaccinations (within 4 weeks) was reported as none. Patient family medical history was reported as none. It was reported that the patient received the first dose of the Pfizer COVID 19 vaccine on 29Jan2021 at 13:30 PM in the right arm. She never had any effects after the first dose but then people were telling her that the second shot was really bad. Now she was concerned and wanted to ask about expected side effects for the second shot. The patient was worried about the second shot and noticed a metallic taste in her mouth on 05Feb2021 (reported as starting last Friday) and duration of reaction was reported as 2 days. The patient also experienced stomach burning on 05Feb2021 (reported as starting last Friday). The patient stomach burning was reported as worsened. She was scheduled to get the next dose of the vaccine on 19Feb2021. Relevant test was reported as none. Outcome of the event taste metallic was recovered on 07Feb2021 and for stomach burning was not recovered.  Follow-up attempts completed. No further information expected
PATIENT HAD DIFFICULTY BREATHING, SHORTNESS OF BREATH, AND NAUSEA, HIVES ON TRUNK AND ARMS, INCIDENT OCCURRED WITHIN ONE HALF HOUR AFTER VACCINATION, EMERGENCY PERSONNEL NOTIFIED, PATIENT TRANSPORTED VIA AMBULANCE TO EMERGENCY ROOM, PATIENT RECEIVED EPINEPHRINE, BENADRYL, AND PREDNISONE AT EMERGENCY ROOM. LEFT ER THAT DAY, WENT BACK TO URGENT CARE THE FOLLOWING DAY, WAS NOT TREATED. WENT BACK TO EMERGENCY ROOM TWO DAYS AFTER VACCINATION, RECEIVED MORE EPINEPHRINE, SOLUMEDROL, AND BENADRYL AND SENT HOME. NO INPATIENT STAYS. FOLLOWED UP WITH PRIMARY CARE WHO DISCONTINUED CURRENT ANTIBIOTIC OF BIAXIN AND ADVISED TO NOT RECEIVE INFLUENZA VACCINATION IN SUBSEQUENT YEARS.
Raised erythematous patchy rash of left shoulder (Behind left deltoid muscle) with slight vesicles. Also similar linear rash on left leg (appearance of delayed hypersensitivity) rash began 1 week after injection.
I started feeling chills, which I have never had before, pain in legs, and my whole body was sore. My first visit for that was in April. They did x-ray of my back, ENG, CAT scan, Echocardiogram. One of the tests showed I had lumbar spinal stenosis. Tomorrow I go see the doctor.
After receiving the vaccine client verbalized light headedness and dizziness.  Client was evaluated by onsite paramedics and symptoms resolved within mins.  Client was released to go home at 11:05 am per Fire Rescue.
RN administered vaccine SQ rather then IM,.. Large area of induration @4x3 inches formed on back of right arm- dark red, painful, swollen and itchy.  This started to develop around 10-12 hours after the injection. Also low grade fever 100.6F. Examined by father who is an RN at home and reported to clinic.
About 5.30pm arm was sore.  By 8pm started to get chills and temperature started to rise--highest was 102.3. Patient was not sure if took medicine for fever. Patient had to pile up with blankets.  Next day, called doctor and nurse called back and told patient to take Tylenol and Benadryl.  Patient still did not feel good and had some fever.    On Thursday, patient woke up in soaking in bed.  Patient was fine by Saturday and has had no problems since.
Pain in both eyes when he moved them with sensitivity to light and swelling, dizziness, head would hurt if he moved it quickly, pain in his lower back, fatigue, malaise, sore throat.
Slightly less than 24 hours post my second vaccine, experienced headache, significant body aches, and fatigue. No fever. But symptoms required me to lay down/rest, and I?m healthy and active. Symptoms persisted for approximately 4-5 hours.
Received Varicella and Hepatitis A vaccine in L arm on day prior to visit. This AM noted significant swelling erythema @ injection site. Area of erythema about 4cm diameter. Pt given hydrocortisone, BENADRYL.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. Pertinent medical history or drug allergies/drug reactions were not reported. On 24-MAR-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (dose, route, lot number and expiration date were not provided). Concomitant medication was not provided. No adverse effect was reported. No product quality complaint (PQC) was involved. This is one of nine reports from the same reporter. Additional information has been requested.
Varicella vaccine given on 09/06/01. On 09/20/01, papular and vesicular rash right lateral hip at the injection site. No fever, 5 vesicles, 3 papules on the chest
Information has been received from a physician concerning a pediatric patient who was vaccinated subcutaneously with the second 0.5 ml dose of VARIVAX (Oka/Merck) over the last six months. The patient developed injection site reactions after being vaccinated with the second dose. The reactions included redness, swelling and local heat. The outcome was unknown. The patient sought medical attention and was treated with antibiotics. This is one of several reports received from the same source. Additional information has been requested.
localized rxn to left arm injection site. Hot to touch, red, itchy, painful. ABX ordered.
I have had whole body myalgias since the first day of the vaccine. I am now 19 days since the vaccine and continue to feel them most of the day. They were the most intense the first weeks but have improved slightly since then. I also have had fatigue during this time period with occasional headaches. I have had lightheadedness for the past week.
PT HAD MINOR BLEEDING THAT STOPPED WITHIN 3 SECONDS OF NEEDLE WITHDRAWAL; HOWEVER A WELT SOON FORMED THAT GREW TO MAXIMUM 1 INCH DIAMETER, 1CM HIGH WITHIN 30 SECONDS. PT WAS SAT BY PHARAMCY FOR OBSERVATION FOR 30 MINUTES AFTERWARDS. SHE INDICATED NO ADVERSE REACTION (PAIN, DIZZINESS, ETC). IT SEEMED MERELY TO BE A LARGE WELT. BY END OF 30 MIN, WELT HAD SHRUNK BY MORE THAN HALF ORIGINAL SIZE.  PT WAS COUNSELED ON SIGNS/SYMPTONS OF CLOTTING, INTERNAL BLEEDING, BRUISING. WHEN TO SEEK MEDICAL HELP, AND TO REACH OUT TO US IF ANYTHING DEVELOPES.
Near fainting- vasovagal syncope. Symptoms of lightheadedness, weakness, dizziness, almost fainting. Recovered after about 5 minutes of sitting down. 8 weeks normal pregnancy.
Shortly after midnight on same day as vaccine, started a fever, slight headache, chills and uncontrollable shaking. Fever stayed for 3 days and had several pock marks on cheek and in hairline.
SORE WRIST JOINT; GENERAL ITCHINESS; FACIAL REDNESS; JAW TINGLING; FEELING WARM; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included allergic reaction, fatigue, tingling in jaw, and feeling of wind burn on face, and concurrent conditions included idiopathic angioedema, seasonal allergies, pet allergies, drug sensitivity, and breast feeding. The patient was previously treated with epinephrine for allergic reaction. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included ascorbic acid/biotin/minerals Nos/nicotinic acid/retinol/tocopherol/vitamin b Nos/vitamin d Nos for supplementation for breast feeding, fexofenadine for idiopathic angioedema, and covid-19 vaccine for prophylactic vaccination. On 08-APR-2021, the subject experienced sore wrist joint. On 08-APR-2021, the subject experienced general itchiness. On 08-APR-2021, the subject experienced facial redness. On 08-APR-2021, the subject experienced jaw tingling. On 08-APR-2021, the subject experienced feeling warm. Treatment medications (dates unspecified) included: naproxen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from general itchiness, sore wrist joint, facial redness, jaw tingling, and feeling warm. This report was non-serious. This parent/child case is linked to 20210421650.
Patient received 0.2 ml/ 30 mcg instead of the correct dose of 0.2 ml/ 10 mcg. The administrating nurse used the wrong vial by accident .
Patient received shot 4pm- had chinese food then at 11pm started having nausea, cold sweats and severe salivating continued until next day. Also fever. Recovered in 2 days.